Moderate‐severe neurodevelopmental impairment at 18 to 26 months ‐ not measured · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Combined outcome of mortality or BPD at 36 weeks' PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks' PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
All‐cause mortality (between start of intervention and end of · preterm infants
Enteral zinc supplementation may leads to lower all‐cause mortality (between start of intervention and end of compared with no zinc supplementation (low certainty).
1 finding from 1 review
Neurodevelopmental disability at 18 to 24 months among survivors · preterm infants
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Bronchopulmonary dysplasia · preterm infants
Enteral zinc supplementation showed no clear difference in bronchopulmonary dysplasia compared with no zinc supplementation (low certainty).
1 finding from 1 review
Bacterial sepsis · preterm infants
Enteral zinc supplementation showed no clear difference in bacterial sepsis compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm infants
Enteral zinc supplementation showed no clear difference in necrotising enterocolitis compared with no zinc supplementation (low certainty).
1 finding from 1 review
Growth · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure of PDA closure within 1 week of administration of the first dose of indomethacin · symptomatic patent ductus arteriosus in preterm infants
Indomethacin leads to lower failure of PDA closure within 1 week of administration of the first… compared with placebo or control (high certainty).
1 finding from 1 review
Bronchopulmonary dysplasia at 28 days · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in bronchopulmonary dysplasia at 28 days compared with placebo or control (low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in bronchopulmonary dysplasia at 36 weeks' gestation compared with placebo or control (low certainty).
1 finding from 1 review
All‐cause neonatal mortality before hospital discharge · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in all‐cause neonatal mortality before hospital discharge compared with placebo or control (moderate certainty).
1 finding from 1 review
Proportion of infants requiring surgical ligation of PDA · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in proportion of infants requiring surgical ligation of PDA compared with placebo or control (moderate certainty).
1 finding from 1 review
NEC ≥ stage II · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in NEC (≥ Bell stage 2) compared with placebo or control (low certainty).
1 finding from 1 review
Mucocutaneous or gastrointestinal bleeding · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in mucocutaneous or gastrointestinal bleeding compared with placebo or control (low certainty).
1 finding from 1 review
Outcomesa · term and late preterm neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure requiring exchange transfusionc,d · term and late preterm neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute bilirubin encephalopathy · term and late preterm neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deathc · term and late preterm neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of rehospitalization within 7 days of discharge for treatment for hyperbilirubinemia · term and late preterm neonates
It is very uncertain whether sunlight (with or without filters or amplification) changes rate of rehospitalization within 7 days of discharge for treatment… compared with no treatment (very low certainty).
1 finding from 1 review